Industry: Pharmaceuticals, Biotechnology
GENOVAC pioneered the development of genetic immunization and has an unmet track record of more than 800 projects. Over eight years we have established a series of immunization plasmids and strategies allowing us to choose the best possible strategy to meet the demands of our clients and to ensure highest quality of our products. We offer basic (low budget) and optimized strategies: For basic approaches (polyclonal) you provide the expression plasmids (inclusive leader), whereas for optimized projects (polyclonal and/or monoclonal) we choose a strategy and use our IP-protected immunization plasmids. The optimized strategy is applicable to any protein. In order to assess which optimized strategy will apply for your antigen, please fill out our free questionnaire. ( www.genovac.com )
GENOVAC GmbH
3233 15Th Street South
Fargo, North Dakota 58104
USA
Tel: (515) 201-1199